GF Fund Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.75K Hold
650
﹤0.01% 607
2025
Q1
$8.57K Buy
650
+116
+22% +$1.53K ﹤0.01% 583
2024
Q4
$9.56K Buy
+534
New +$9.56K ﹤0.01% 551